[Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
D000700:Analgesics; D000779:Anesthetics, Local; D000818:Animals; D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D003061:Codeine / Q000494:pharmacology; D003248:Constipation / Q000139:chemically induced; D004285:Dogs; D004562:Electrocardiography; D004569:Electroencephalography; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009019:Morphinans / Q000494:pharmacology* / Q000633:toxicity; D009269:Nalorphine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013268:Stimulation, Chemical; D013874:Thiopental / Q000494:pharmacology; D013997:Time Factors
D000700:Analgesics; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D006634:Histamine H1 Antagonists; D009019:Morphinans; D010424:Pentobarbital; D013874:Thiopental; D009269:Nalorphine; D003061:Codeine; D010433:Pentylenetetrazole